These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16886351)

  • 1. [Resistance to intestinal opportunistic infections using Cryptosporidium sp. as an example].
    Siński E
    Wiad Parazytol; 2000; 46(1):29-40. PubMed ID: 16886351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
    Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
    Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of murine intestinal intraepithelial lymphocytes and lamina propria lymphocytes against primary and challenge infections with Cryptosporidium parvum.
    Guk SM; Yong TS; Chai JY
    J Parasitol; 2003 Apr; 89(2):270-5. PubMed ID: 12760640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host immune response to Cryptosporidium parvum infection.
    Petry F; Jakobi V; Tessema TS
    Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the mucosal immune system due to Cryptosporidium parvum infection in normal mice.
    Huang DS; Lopez MC; Wang JY; Martinez F; Watson RR
    Cell Immunol; 1996 Nov; 173(2):176-82. PubMed ID: 8912874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
    Jakobi V; Petry F
    Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses.
    Flanigan TP
    Am J Trop Med Hyg; 1994; 50(5 Suppl):29-35. PubMed ID: 8203720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cryptosporidiosis: current views of its pathogenesis and resistance].
    Goncharov DB; Kobets NB; Nagurskaia EV
    Med Parazitol (Mosk); 2007; (1):56-60. PubMed ID: 17436736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects.
    Pinlaor S; Mootsikapun P; Pinlaor P; Pipitgool V; Tuangnadee R
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):841-5. PubMed ID: 16295534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipients.
    Tessema TS; Dauber E; Petry F
    Vaccine; 2009 Nov; 27(47):6575-81. PubMed ID: 19717136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immunity against Cryptosporidium infection.
    Gomez Morales MA; Pozio E
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Oct; 2(3):291-301. PubMed ID: 12476493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune responses against Cryptosporidium parvum infection.
    McDonald V; Korbel DS; Barakat FM; Choudhry N; Petry F
    Parasite Immunol; 2013 Feb; 35(2):55-64. PubMed ID: 23173616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of humoral immunity in Cryptosporidium spp. infection. Studies with B cell-depleted mice.
    Taghi-Kilani R; Sekla L; Hayglass KT
    J Immunol; 1990 Sep; 145(5):1571-6. PubMed ID: 2384671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parasitic infection in immunocompromised patients].
    Derouin F
    Rev Prat; 2007 Jan; 57(2):167-73. PubMed ID: 17432521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals.
    Frost FJ; Tollestrup K; Craun GF; Fairley CK; Sinclair MI; Kunde TR
    J Infect Dis; 2005 Aug; 192(4):618-21. PubMed ID: 16028130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of antibody responses to Cryptosporidium parasites in men at high risk of HIV infection.
    Sandhu SK; Priest JW; Lammie PJ; Hubbard A; Colford JM; Eisenberg JN
    J Infect Dis; 2006 Nov; 194(10):1428-37. PubMed ID: 17054073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies.
    McDonald V
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1077-86. PubMed ID: 22029525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice.
    Ehigiator HN; McNair N; Mead JR
    Exp Parasitol; 2007 Feb; 115(2):107-13. PubMed ID: 16920103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection.
    Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M
    Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.